Catabasis Pharmaceuticals, Inc.

Sirtris Pharmaceuticals, Inc.

Milne, Jill C.

Ting, Amal

Jirousek, Michael R.

Vu, Chi B.

Bemis, Jean E.

Jill C Milne

Jean E Bemis

Chi B Vu

Michael R Jirousek

Jesse J Smith

Joseph J Nunes

Roger Xie

Pui Yee Ng

Jeremy S Disch

Amal Ting

David M Armistead

Thomas Salzmann

Michael V Milburn

Olivier D Boss

Allison Wensley

Jesse Smith

Amy Lynch

David Carney

Andre Iffland

Karl D Normington

The invention relates to fatty acid niacin conjugates; compositions comprising an effective amount of a fatty acid niacin conjugate; and methods for treating or preventing an metabolic disease comprising the administration of an effective amount of a fatty acid niacin conjugate.

Fatty acid niacin conjugates and their uses

The invention relates to fatty acid acylated salicylate derivatives; compositions comprising an effective amount of a fatty acid acylated salicylate derivative; and methods for treating or preventing an inflammatory disorder comprising the administration of an effective amount of a fatty acid acylated salicylate derivative.

Fatty acid acylated salicylates and their uses

The invention relates to niacin conjugated fatty acid mixtures; compositions comprising an effective amount of a niacin conjugated fatty acid mixture; and methods for treating or preventing an metabolic disorder comprising the administration of as effective amount of a niacin conjugated fatty acid mixture.

Niacin conjugated fatty acid mixtures and their uses

The invention relates to Fatty Acid Acetylated Salicylate Derivatives; compositions comprising an effective amount of a Fatty Acid Acetylated Salicylate Derivative; and methods for treating or preventing an inflammatory disorder comprising the administration of an effective amount of a Fatty Acid Acetylated Salicylate Derivative.

Fatty acid acetylated salicylates and their uses

The invention relates to Fatty Acid Fumarate Derivatives; compositions comprising an effective amount of a Fatty Acid Fumarate Derivative; and methods for treating or preventing cancer, a metabolic disorder or neurodegenerative disorder comprising the administration of an effective amount of a Fatty Acid Fumarate Derivative.

Fatty acid fumarate derivatives and their uses

The invention relates to fatty acid COX inhibitor derivatives; compositions comprising an effective amount of a fatty acid COX inhibitor derivative; and methods for treating or preventing a metabolic, autoimmune, inflammatory, or neurodegenerative disorder comprising the administration of an effective amount of a fatty acid COX inhibitor derivative.

Fatty acid COX inhibitor derivatives and their uses

The invention relates to fatty acid guanidine or salicylate guanidine derivatives; compositions comprising an effective amount of a fatty acid guanidine or salicylate guanidine derivative; and methods for treating or preventing a metabolic disease comprising the administration of an effective amount of a fatty acid guanidine or salicylate guanidine derivative.

Fatty acid guanidine and salicylate guanidine derivatives and their uses

The invention relates to fatty acid statin conjugates and fatty acid FXR agonist conjugates; compositions comprising an effective amount of a fatty acid statin conjugate or a fatty acid FXR agonist conjugate; and methods for treating or preventing a metabolic disease comprising the administration of an effective amount of a fatty acid statin conjugate or a fatty acid FXR agonist conjugate.

Fatty acid conjugates of statin and FXR agonists; compositions and method of uses

The invention relates to fatty acid lenalidomide derivatives; compositions comprising an effective amount of a fatty acid lenalidomide derivative; and methods for treating or preventing a metabolic disease comprising the administration of an effective amount of a fatty acid lenalidomide derivative.

Fatty acid lenalidomide derivatives and their uses

Growing community of inventors

Brookline, MA, United States of America

Jill C Milne